Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
6.63
+0.14 (2.16%)
At close: Jul 2, 2024, 4:00 PM
6.87
+0.24 (3.62%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
4117861,276991--
Market Cap Growth
-47.69%-38.37%28.74%---
Enterprise Value
3707321,263915137
PE Ratio
--15.88-29.80-47.77--
PS Ratio
2.104.209.0010.50--
PB Ratio
3.255.7021.0810.65--
P/FCF Ratio
-20.96-17.08-28.05-49.81--
P/OCF Ratio
-32.84-22.74-41.63-57.65--
EV/Sales Ratio
1.893.918.909.690.220.18
EV/EBITDA Ratio
-18.76-20.03-37.41-57.8640.43-2.69
EV/EBIT Ratio
-15.44-16.50-32.88-55.46-14.48-2.07
EV/FCF Ratio
-19.90-15.90-27.77-45.97-2.32-0.80
Debt / Equity Ratio
0.550.501.130.3239.926.08
Debt / EBITDA Ratio
-1.70-1.89-2.02-1.8697.11-7.31
Debt / FCF Ratio
-1.80-1.50-1.50-1.48-5.57-2.16
Quick Ratio
2.983.583.656.832.813.08
Current Ratio
3.984.414.417.583.533.90
Asset Turnover
0.800.760.910.821.60-
Interest Coverage
-9.53-8.59-8.74-4.06-0.32-4.07
Return on Equity (ROE)
-39.70%-34.00%-60.90%-28.40%-218.80%-
Return on Assets (ROA)
-22.20%-20.00%-27.60%-18.10%-12.00%-
Return on Capital (ROIC)
-28.94%-24.86%-27.06%-13.48%2.69%-15.79%
Earnings Yield
-13.32%-6.30%-3.36%-2.09%--
FCF Yield
-9.35%-5.85%-3.56%-2.01%--
Buyback Yield / Dilution
-5.23%-10.09%-14.17%-30.61%-0.43%-
Total Shareholder Return
-5.23%-10.09%-14.17%-30.61%-0.43%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).